| Schedule of Potentially Dilutive Securities Not Included in the Computation of Diluted Net (Loss) Income Per Share of Common Stock |
The following table presents potentially dilutive securities that were not included in the computation of diluted net (loss) income per share of common stock as their inclusion would have been anti-dilutive and/or their issuance upon satisfying a contingency, if applicable, was not satisfied or deemed satisfied as of period end:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Akerna Common Warrants |
|
|
1,449 |
|
|
|
— |
|
|
|
1,449 |
|
|
|
— |
|
Akerna Underwriter Warrants |
|
|
72 |
|
|
|
— |
|
|
|
72 |
|
|
|
— |
|
Restricted stock units |
|
|
128,549 |
|
|
|
— |
|
|
|
128,549 |
|
|
|
— |
|
Total |
|
|
130,070 |
|
|
|
— |
|
|
|
130,070 |
|
|
|
— |
|
|
| Summary of Reconciliation of the Denominator of the Basic and Diluted Net Income (Loss) Per Share of Common Stock Computations |
The following is a reconciliation of the denominator of the basic and diluted net (loss) income per share of common stock computations for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
(in USD thousands, except share and per share amounts) |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income – basic |
|
$ |
(57,151 |
) |
|
$ |
3,431 |
|
|
$ |
(138,943 |
) |
|
$ |
(97,192 |
) |
Gryphon warrants revaluation included in net (loss) income (net of income tax benefit)(1) |
|
|
(17 |
) |
|
|
— |
|
|
|
(72 |
) |
|
|
— |
|
Net (loss) income – diluted |
|
$ |
(57,168 |
) |
|
$ |
3,431 |
|
|
$ |
(139,015 |
) |
|
$ |
(97,192 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares of Class A common stock |
|
|
22,667,057 |
|
|
|
10,635,825 |
|
|
|
20,863,503 |
|
|
|
10,635,825 |
|
Weighted average shares of Class B common stock |
|
|
48,814,987 |
|
|
|
48,814,987 |
|
|
|
48,814,987 |
|
|
|
48,814,987 |
|
Total weighted average shares of common stock outstanding – basic |
|
|
71,482,044 |
|
|
|
59,450,812 |
|
|
|
69,678,490 |
|
|
|
59,450,812 |
|
Dilutive impact of Gryphon Warrants |
|
|
5,364 |
|
|
|
— |
|
|
|
2,697 |
|
|
|
— |
|
Total weighted average shares of common stock outstanding – diluted |
|
|
71,487,408 |
|
|
|
59,450,812 |
|
|
|
69,681,187 |
|
|
|
59,450,812 |
|
Net (loss) income per share of common stock: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.80 |
) |
|
$ |
0.06 |
|
|
$ |
(1.99 |
) |
|
$ |
(1.63 |
) |
Diluted |
|
$ |
(0.80 |
) |
|
$ |
0.06 |
|
|
$ |
(2.00 |
) |
|
$ |
(1.63 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Calculated as the net adjustment from warrant liability fair value remeasurement from Gryphon Warrants, net of tax |
|
|
|
|
|